MARKER THERAPEUTICS, INC. Cash Equivalents, at Carrying Value
MARKER THERAPEUTICS, INC. (MRKR) had Cash Equivalents, at Carrying Value of $4.30 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2018-11-13
- 2018-09-30: Cash Equivalents, at Carrying Value $4.30M.
- 2018-06-30: Cash Equivalents, at Carrying Value $7.80M.
- 2018-03-31: Cash Equivalents, at Carrying Value $2.80M.
- 2017-09-30: Cash Equivalents, at Carrying Value $7.60M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2018-09-30 | $4.30M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $7.80M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.80M 10-Q · filed 2018-05-15 |
| 2017-09-30 | $7.60M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $9.96M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $5.93M 10-Q · filed 2017-05-05 |
| 2016-09-30 | $9.59M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $3.77M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $5.72M 10-Q · filed 2016-05-16 |
| 2015-09-30 | $6.09M 10-Q/A · filed 2016-04-14 |
| 2015-06-30 | $3.10M 10-Q/A · filed 2016-04-14 |
| 2015-03-31 | $1.45M 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |